ADME pharmacogenetics: future outlook for Russia

Pharmacogenomics. 2019 Jul;20(11):847-865. doi: 10.2217/pgs-2019-0013. Epub 2019 Aug 1.

Abstract

This systematic review reflects the results of pharmacogenetic studies in the Russian Federation aimed at studying the genes involved in the drug biotransformation system. The works of Russian researchers found by us are mostly devoted to microsomal liver oxidation enzymes (metabolism) and membrane transporter systems (absorption and excretion). This review presents population-ethnic and associative clinical studies on the genes of the CYP450 system, noncytochrome oxidation enzymes (SULT1A1, CES1), membrane transporter system genes (ABCB1, SLCO1B1) and warfarin biotransformation enzymes (VKORC1, GGCX). The information is structured in the form of 11 tables, divided by regions of the Russian Federation.

Keywords: ADME; P450; Russia; cardiology; personalized medicine; pharmacogenomics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Alleles
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Cytochrome P-450 Enzyme System / genetics*
  • Genotype
  • Humans
  • Inactivation, Metabolic / genetics*
  • Pharmacogenetics / trends*
  • Russia / epidemiology
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin
  • Cytochrome P-450 Enzyme System